Buy 100% Authentic Products from Hamza Surgical. Cash on Delivery is unavailable due to wholesale prices and courier 17 percent deductions on COD amounts. Thanks for your understanding!
Buy 100% Authentic Products from Hamza Surgical. Cash on Delivery is unavailable due to wholesale prices and courier 17 percent deductions on COD amounts. Thanks for your understanding!
Origin & Founding BioHermes is a high-tech in vitro diagnostics (IVD) company based in Wuxi, Jiangsu, China, founded in 2006 by Dr. Eric Xu and Yan Liu.
Technological Roots The company acquired innovative HbA1c testing technology from Scripps Laboratories in 2013, which accelerated its development of point-of-care glycohemoglobin analyzers.
Global Reach BioHermes products are used in over 100 countries, spanning clinics, laboratories, and hospitals worldwide.
Product Evolution & Milestones
Year
Milestone
2013
Development of Boronate Affinity Chromatography for HbA1c testing.
2014–2019
Launch of successive products: A1C EZ, A1C EZ 2.0, handheld analyzers, A1cChek Pro, A1cChek Express.
2021
Introduction of BH60 Automated Glycohemoglobin Analyzer (HPLC-based).
2023–2024
Expansion into immunofluorescence analyzers—Multi-function handheld and BF-300 models.
Product Lines & Capabilities
HbA1c Analyzers Models like A1C EZ 2.0, A1cChek Pro, and A1cChek Express provide rapid, point-of-care HbA1c testing using boronate affinity chromatography.
Advanced Platform The BH60 Automated Glycohemoglobin Analyzer leverages HPLC methodology, serving clinical laboratories with higher-throughput needs.
Immunofluorescence & Coagulation Testing BioHermes has added multi-channel immunofluorescence analyzers and thromboelastograph (coagulation) analyzers to its portfolio, offering versatile options for chronic disease and coagulation monitoring.
GluCoA1c Analyzer The GluCoA1c Blood Glucose and Glycohemoglobin Analyzer uniquely measures both blood glucose and HbA1c from a single device, ideal for streamlined diabetes management.
Regulatory Status
Products like the BioHermes A1C EZ 2.0 Glycohemoglobin Analyzer and the corresponding Test Kit (A1C-S22) are registered within the U.S. FDA’s Global Unique Device Identification Database (GUDID). They are not classified as prescription or over-the-counter but are available commercially.
Vision & Expansion
BioHermes emphasizes convenient, accurate, and low-cost HbA1c testing solutions — facilitating frequent monitoring across various care settings.
Celebrated milestones include being the first Chinese manufacturer to receive U.S. FDA 510(k) clearance and recognition by FIND Diagnosis among top global point-of-care HbA1c methodologies.
In Summary
BioHermes is a reputable biotech firm specializing in rapid and accessible diabetes diagnostic tools. For nearly two decades, they’ve developed a robust range of analyzers—from portable HbA1c meters to sophisticated HPLC systems and beyond. Their commitment to innovation and global quality standards (including FDA recognition) positions them as a reliable partner in chronic disease management.